S6K1 amplification confers innate resistance to CDK4/6 inhibitors through activating c-Myc pathway in patients with estrogen receptor-positive breast cancerHongnan Mo, Fei Ma, Yu Xue et al.|Molecular Cancer|2022Cited by 57